CU23286A3 - MÃ0 / 00 EVERYTHING TO OBTAIN VACCINES FOR THE TREATMENT OF INFECTIONS CAUSED BY FLAVIVIRUS AND VACCINES OBTAINED - Google Patents
MÃ0 / 00 EVERYTHING TO OBTAIN VACCINES FOR THE TREATMENT OF INFECTIONS CAUSED BY FLAVIVIRUS AND VACCINES OBTAINEDInfo
- Publication number
- CU23286A3 CU23286A3 CU1999120A CU1999120A CU23286A3 CU 23286 A3 CU23286 A3 CU 23286A3 CU 1999120 A CU1999120 A CU 1999120A CU 1999120 A CU1999120 A CU 1999120A CU 23286 A3 CU23286 A3 CU 23286A3
- Authority
- CU
- Cuba
- Prior art keywords
- vaccines
- flavivirus
- everything
- treatment
- prm
- Prior art date
Links
- 241000710831 Flavivirus Species 0.000 title abstract 3
- 208000015181 infectious disease Diseases 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title 2
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 241000710772 Yellow fever virus Species 0.000 abstract 2
- 239000002773 nucleotide Substances 0.000 abstract 2
- 125000003729 nucleotide group Chemical group 0.000 abstract 2
- 229940051021 yellow-fever virus Drugs 0.000 abstract 2
- 241000700605 Viruses Species 0.000 abstract 1
- 230000002238 attenuated effect Effects 0.000 abstract 1
- 230000002458 infectious effect Effects 0.000 abstract 1
- 230000004853 protein function Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Un virus quimérico vivo, infeccioso, atenuado que contiene un virus de la fiebre amarilla, en el cual la secuencia de nucleótidos para una proteÃna prM-E está ya sea suprimida, trunca o mutada, de modo que la proteÃna prM-E funcional no sea expresada e integrada en el genoma del virus de la fiebre amarilla, una secuencia de nucleótidos que codifica una proteÃna prM-E de un segundo flavivirus diferente, de modo que la proteÃna prM-E del segundo flavivirus sea expresada.</P>A live, infectious, attenuated chemical virus that contains a yellow fever virus, in which the nucleotide sequence for a prM-E protein is either suppressed, truncated or mutated, so that the prM-E protein function is not expressed and integrated into the genome of the yellow fever virus, a nucleotide sequence that encodes a prM-E protein of a second different flavivirus, so that the prM-E protein of the second flavivirus is expressed. </ P >
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU1999120A CU23286A3 (en) | 1999-08-30 | 1999-08-30 | MÃ0 / 00 EVERYTHING TO OBTAIN VACCINES FOR THE TREATMENT OF INFECTIONS CAUSED BY FLAVIVIRUS AND VACCINES OBTAINED |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU1999120A CU23286A3 (en) | 1999-08-30 | 1999-08-30 | MÃ0 / 00 EVERYTHING TO OBTAIN VACCINES FOR THE TREATMENT OF INFECTIONS CAUSED BY FLAVIVIRUS AND VACCINES OBTAINED |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CU23286A3 true CU23286A3 (en) | 2008-06-30 |
Family
ID=40122432
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU1999120A CU23286A3 (en) | 1999-08-30 | 1999-08-30 | MÃ0 / 00 EVERYTHING TO OBTAIN VACCINES FOR THE TREATMENT OF INFECTIONS CAUSED BY FLAVIVIRUS AND VACCINES OBTAINED |
Country Status (1)
| Country | Link |
|---|---|
| CU (1) | CU23286A3 (en) |
-
1999
- 1999-08-30 CU CU1999120A patent/CU23286A3/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1951296T3 (en) | Cell-derived viral vaccines with low levels of residual cell DNA | |
| ECSP093601A (en) | PROTEINS DERIVED FROM THE WHITE SPOT SYNDROME VIRUS AND ITS USES | |
| Diagne et al. | Vector competence of Aedes aegypti and Aedes vittatus (Diptera: Culicidae) from Senegal and Cape Verde archipelago for West African lineages of chikungunya virus | |
| ATE297757T1 (en) | CHIMERIC VACCINES AGAINST FLAVIVIRUS | |
| AR020134A1 (en) | IMMUNOLOGICAL ANTIGENS AGAINST THE SIMPLEX HERPES VIRUS AND METHODS FOR THE USE OF THE SAME | |
| CY1109036T1 (en) | VACCINE INCLUDES A VANISHED VIRUS | |
| IL202978A0 (en) | West nile virus vaccine | |
| TNSN06071A1 (en) | Use of modified cyclosporins for the treatment of hcv disorders | |
| ATE364624T1 (en) | MULTISYSTEMIC CRIME GROWTH SYNDROME CAUSED BY VIRUSES IN PIGS | |
| EA200870304A1 (en) | PSEUDOINFECTIONAL FLAVIVIRUS AND ITS APPLICATION | |
| CY1107786T1 (en) | EXPRESSION SYSTEMS AND RECOVERABLE RSV VACCINASE VACCINES | |
| UY32715A (en) | USEFUL PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF HEPATITIS C (HCV) VIRUSES, USES AND RELATED METHODS | |
| MXPA05005203A (en) | Vaccine against hcv. | |
| UY32720A (en) | PHARMACEUTICAL COMBINATIONS USEFUL FOR THE TREATMENT OF HEPATITIS C (HCV) VIRUSES, USES AND RELATED METHODS | |
| ATE517184T1 (en) | HCV NS3/4A CODING NUCLEIC ACID | |
| BR0108499A (en) | Hepatitis c therapeutic agent | |
| WO2002072803A3 (en) | Subgenomic replicons of the flavivirus dengue | |
| CO5280138A1 (en) | DAMAGED AND INNOCUTIVE VIRUSES OF THE VIRICA BOVINA DIARREA FOR IN MANAGING COWS | |
| AR067439A1 (en) | ANTIGENIC CHEMICAL VIRUSES OF ST. LOUIS / VIRUS DENGUE TYPE 4 | |
| EP2977457A3 (en) | Idna vaccines and methods for using the same | |
| NO20005608D0 (en) | Structural proteins of fish pancreatic disease virus and applications thereof | |
| CU23286A3 (en) | MÃ0 / 00 EVERYTHING TO OBTAIN VACCINES FOR THE TREATMENT OF INFECTIONS CAUSED BY FLAVIVIRUS AND VACCINES OBTAINED | |
| AR027291A1 (en) | PRRSV RECOMBINATING ATTENTION | |
| BRPI0410967A (en) | compounds, compositions and their uses for the treatment of virus infections of the family flaviviridae | |
| AR027443A1 (en) | MUTANTS OF EHV gM-NEGATIVES |